Cargando…
Enisamium is a small molecule inhibitor of the influenza A virus and SARS-CoV-2 RNA polymerases
Influenza A virus and coronavirus strains cause a mild to severe respiratory disease that can result in death. Although vaccines exist against circulating influenza A viruses, such vaccines are ineffective against emerging pandemic influenza A viruses. Currently, no vaccine exists against coronaviru...
Autores principales: | Walker, Alexander P, Fan, Haitian, Keown, Jeremy R, Margitich, Victor, Grimes, Jonathan M, Fodor, Ervin, te Velthuis, Aartjan J W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7263517/ https://www.ncbi.nlm.nih.gov/pubmed/32511388 http://dx.doi.org/10.1101/2020.04.21.053017 |
Ejemplares similares
-
Enisamium Reduces Influenza Virus Shedding and Improves Patient Recovery by Inhibiting Viral RNA Polymerase Activity
por: te Velthuis, Aartjan J. W., et al.
Publicado: (2021) -
Enisamium Inhibits SARS-CoV-2 RNA Synthesis
por: Elli, Stefano, et al.
Publicado: (2021) -
Enisamium is an inhibitor of the SARS-CoV-2 RNA polymerase and shows improvement of recovery in COVID-19 patients in an interim analysis of a clinical trial
por: Holubovska, Olha, et al.
Publicado: (2021) -
In Vitro Bioavailability Study of an Antiviral Compound Enisamium Iodide
por: Haltner-Ukomadu, Eleonore, et al.
Publicado: (2018) -
Structural insights into RNA polymerases of negative-sense RNA viruses
por: te Velthuis, Aartjan J. W., et al.
Publicado: (2021)